Status:
COMPLETED
Response of Patients on Surveillance for Prostate Cancer to Dutasteride
Lead Sponsor:
Sunnybrook Health Sciences Centre
Collaborating Sponsors:
Toronto Sunnybrook Regional Cancer Centre
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Hypothesis: That, in men on surveillance for favorable risk prostate cancer treated with dutasteride, prostate specific antigen (PSA) kinetics is of value in identifying those men who harbor occult hi...
Detailed Description
This analysis is a subset of the data associated with the active surveillance cohort at Sunnybrook Health Sciences Centre. Approximately 150 subjects within the cohort have received dutasteride therap...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients on active surveillance for favorable risk prostate cancer who have been treated with dutasteride following the diagnosis of cancer.
Exclusion
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01525914
Start Date
May 1 2010
End Date
August 1 2010
Last Update
February 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5